Leaflet KIVIZIDIALE 40mcg / 5mg / ml ophthalmic drops solution

Product code:
W68429001
Quantity:
1
Indicated for:
glaucoma; ocular hypertension
Route of administration:
ophthalmic
Substance:
travoprost + timolol (glaucoma agent + beta blocker)
ATC
S01ED51 — Sensory organs | Antiglaucoma preparations and miotics | Beta blocking agents

Precautions:

Dizziness / vertigo

This medicine may cause dizziness or vertigo.

Hypotension / fall risk

May lower blood pressure and increase the risk of falls.

Elderly warning

Older people may have an increased risk of side effects.

Travoprost+timolol is a combination medication used in the treatment of open-angle glaucoma and ocular hypertension. Travoprost is a prostaglandin F2-alpha analog that reduces intraocular pressure by increasing the outflow of aqueous humor, while timolol is a beta-blocker that decreases aqueous humor production.

This combination is administered as eye drops, usually once daily in the evening. It is indicated for patients who do not respond adequately to monotherapy or require additional intraocular pressure reduction.

Common side effects include ocular irritation, conjunctival hyperemia, dry eyes, and a burning sensation. In rare cases, systemic adverse reactions such as bradycardia, hypotension, or respiratory difficulties may occur. It is important for patients to follow their doctor's instructions and avoid contact of the dropper tip with the eye or other surfaces.

Travoprost+timolol is an effective therapeutic option for managing elevated intraocular pressure, helping to prevent optic nerve damage and vision loss.

General data about KIVIZIDIALE 40mcg / 5mg / ml

Substance:
travoprost + timolol
Date of latest medicines list:
01-06-2026
Product code:
W68429001
Concentration:
40mcg / 5mg / ml
Pharmaceutical form:
ophthalmic drops solution
Quantity:
1
Product type:
Generic medicine
Price:
47.93 RON
Prescription status:
P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Marketing authorisation

Manufacturer:
PHARMATHEN SA - CROATIA
Holder:
BAUSCH + LOMB IRELAND LIMITED - IRLANDA
Number:
15063/2023/01
Shelf life:
3 years-after packing for marketing;after the first opening of the bottle-28 days

Compensation lists for KIVIZIDIALE 40mcg / 5mg / ml Bausch & Lomb

G26 (C1) - Glaucoma

Price
47.93 RON
Copayment
46.40 RON
Patient
1.53 RON

GX (C1) - GENERIC (used in compensation list, C1, for another diagnosis)

Price
47.93 RON
Copayment
46.40 RON
Patient
1.53 RON